Analyst emphasizes 2021 guidance in Genmab fiscal report

On Tuesday, Danish biotech firm Genmab presents its annual report, and according to bank analyst Søren Løntoft Hansen, special attention will be given to the current year's guidance.
Photo: PR / Genmab
Photo: PR / Genmab

Genmab's 2021 guidance is an unknown variable for when biotech companies start presenting fiscal reports on Tuesday after the stock market closes.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading